Literature DB >> 23296417

Carotid artery stenting in recently symptomatic patients.

C Setacci1, G de Donato, F Setacci, P Sirignano, G Galzerano, M P Borrelli, A Cappelli.   

Abstract

Treatment of acute stroke is time-dependent, with the best outcomes resulting from the earliest interventions. However, for patients with acute ischemic stroke due to a high-grade stenosis of the internal carotid artery, despite maximal medical treatment, an effective intervention to improve their neurologic symptoms and clinical outcome has not yet been established. There are two major concerns: first, cerebral revascularization in the acute stage remains challenging because of the possibility that hemorrhagic infarction or hyperperfusion syndrome will occur after revascularization; second, alarms about carotid artery stenting in patients with acute symptoms are related to the fact that, while with carotid endarterectomy the plaque is completely removed, after stenting it is only remodelled and its stabilization is essential to avoid embolic events during the procedure and in the post-operative period. Although level 1 evidence seems clearly in favor of carotid endarterectomy in symptomatic patients, carotid stenting has been proposed as a possible alternative in selected cases if the procedure is performed in high-volume center with documented low perioperative stroke and death rates. This review summarizes indications and results for carotid artery stenting in recently symptomatic patients.

Entities:  

Mesh:

Year:  2013        PMID: 23296417

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  1 in total

1.  Recent trends in neuroendovascular therapy in Japan: analysis of a nationwide survey--Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2.

Authors:  Nobuyuki Sakai; Shinichi Yoshimura; Waro Taki; Akio Hyodo; Shigeru Miyachi; Yoji Nagai; Chiaki Sakai; Tetsu Satow; Tomoaki Terada; Masayuki Ezura; Toshio Hyogo; Shunji Matsubara; Kentaro Hayashi; Toshiyuki Fujinaka; Yasushi Ito; Shigeki Kobayashi; Masaki Komiyama; Naoya Kuwayama; Yuji Matsumaru; Yasushi Matsumoto; Yuichi Murayama; Ichiro Nakahara; Shigeru Nemoto; Koichi Satoh; Kenji Sugiu; Akira Ishii; Hirotoshi Imamura
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-12-27       Impact factor: 1.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.